Imbalanced IL-1B and IL-18 Expression in Sezary Syndrome
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
SOUSA, Emanuella Sarmento Alho de
NAKAYA, Helder I.
Citação
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, n.5, article ID 4674, 13p, 2023
Resumo
Sezary syndrome (SS) is a rare and aggressive type of cutaneous T-cell lymphoma, with an abnormal inflammatory response in affected skin. The cytokines IL-1B and IL-18, as key signaling molecules in the immune system, are produced in an inactive form and cleave to the active form by inflammasomes. In this study, we assessed the skin, serum, peripheral mononuclear blood cell (PBMC) and lymph-node samples of SS patients and control groups (healthy donors (HDs) and idiopathic erythroderma (IE) nodes) to investigate the inflammatory markers IL-1B and IL-18 at the protein and transcript expression levels, as potential markers of inflammasome activation. Our findings showed increased IL-1B and decreased IL-18 protein expression in the epidermis of SS patients; however, in the dermis layer, we detected increased IL-18 protein expression. In the lymph nodes of SS patients at advanced stages of the disease (N2/N3), we also detected an enhancement of IL-18 and a downregulation of IL-1B at the protein level. Moreover, the transcriptomic analysis of the SS and IE nodes confirmed the decreased expression of IL1B and NLRP3, whereas the pathway analysis indicated a further downregulation of IL1B-associated genes. Overall, the present findings showed compartmentalized expressions of IL-1B and IL-18 and provided the first evidence of their imbalance in patients with Sezary syndrome.
Palavras-chave
Sezary syndrome, lymph nodes, inflammasome, IL-1B, IL-18, erythroderma skin
Referências
- ABRAMS JT, 1991, J INVEST DERMATOL, V96, P31, DOI 10.1111/1523-1747.ep12514693
- Agar NS, 2010, J CLIN ONCOL, V28, P4730, DOI 10.1200/JCO.2009.27.7665
- Akeda T, 2014, ARCH DERMATOL RES, V306, P125, DOI 10.1007/s00403-013-1382-1
- Akilov OE, 2012, EXP DERMATOL, V21, P287, DOI 10.1111/j.1600-0625.2012.01452.x
- Andrews S, 2010, FASTQC QUALITY CONTR
- AXELROD PI, 1992, JAMA-J AM MED ASSOC, V267, P1354, DOI 10.1001/jama.267.10.1354
- Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0
- Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419
- Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121
- Bouaziz JD, 2005, J INVEST DERMATOL, V125, P1273, DOI 10.1111/j.0022-202X.2005.23914.x
- Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147
- Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002
- Cariti C, 2022, J AM ACAD DERMATOL, V86, P943, DOI 10.1016/j.jaad.2021.03.079
- Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417
- Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074
- GAZDAR AF, 1980, BLOOD, V55, P409
- Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
- Hacham M, 2002, EUR CYTOKINE NETW, V13, P55
- Hasegawa T, 2016, BIOCHEM BIOPH RES CO, V477, P329, DOI 10.1016/j.bbrc.2016.06.106
- Hirooka Y, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.639103
- KALTOFT K, 1987, ARCH DERMATOL RES, V279, P293, DOI 10.1007/BF00431220
- Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
- Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214
- Linder A, 2022, METHODS MOL BIOL, V2523, P303, DOI 10.1007/978-1-0716-2449-4_19
- Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
- Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
- Manfrere KCG, 2016, ONCOTARGET, V7, P74592, DOI 10.18632/oncotarget.12816
- Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980
- Miyashiro D, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020936
- Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022
- Mundy-Bosse B, 2018, BLOOD ADV, V2, P1818, DOI 10.1182/bloodadvances.2018020388
- Najidh S, 2021, BLOOD, V138, P2539, DOI 10.1182/blood.2021012286
- Nguyen V, 2008, J AM ACAD DERMATOL, V59, P949, DOI 10.1016/j.jaad.2008.08.030
- Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914
- OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0
- Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749
- Olsen EA, 2016, J AM ACAD DERMATOL, V74, P27, DOI 10.1016/j.jaad.2015.09.033
- Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315
- Rothe MJ, 2005, CLIN DERMATOL, V23, P206, DOI 10.1016/j.clindermatol.2004.06.018
- Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
- Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
- Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849
- Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536
- Torrealba MP, 2018, ONCOTARGET, V9, P3497, DOI 10.18632/oncotarget.23334
- Wilcox RA, 2014, AM J HEMATOL, V89, P838, DOI 10.1002/ajh.23756
- Wise JF, 2013, BLOOD, V121, P4729, DOI 10.1182/blood-2012-12-471094
- Xie Zhuorui, 2021, Curr Protoc, V1, pe90, DOI 10.1002/cpz1.90
- Yamanaka K, 2006, CLIN CANCER RES, V12, P376, DOI 10.1158/1078-0432.CCR-05-1777
- Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995
- Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046
- Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/50
Artigos e Materiais de Revistas Científicas - LIM/53
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/50
Artigos e Materiais de Revistas Científicas - LIM/53